Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Genetics and Genomics›Genomic Imprinting
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Genomic Imprinting

Genetics and Genomics · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 3 min read

The variable phenotypic expression of a GENE depending on whether it is of paternal or maternal origin, which is a function of the dna methylation pattern.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (604 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

The variable phenotypic expression of a GENE depending on whether it is of paternal or maternal origin, which is a function of the dna methylation pattern. Imprinted regions are observed to be more methylated and less transcriptionally active. (Segen, Dictionary of Modern Medicine, 1992)

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Imprinting, Genomic; Imprinting, Genetic; Genetic Imprinting; Parental Imprinting; Imprinting, Parental.

Where it fits in the MeSH classification

Broader topics
Epigenesis, Genetic
See also
DNA Methylation

Related concepts

  • Dna Methylation

Research landscape

PubMed indexes 7,435 records tagged with the MeSH heading “Genomic Imprinting” (counts retrieved 2026-10-29). 877 of them (11.8%) were published from 2020 onward, and the busiest period so far is 2000-2009 with 2,838 records.

Reviews account for 1,678 records (22.6%) and meta-analyses for 12. Randomized controlled trials number 7 (0.1%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 1,159 records; 2000-2009: 2,838 records; 2010-2019: 2,561 records; 2020 onward: 877 records1,159through 19992,8382000-20092,5612010-20198772020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19991,159
2000-20092,838
2010-20192,561
2020 onward877
Share of records by publication typeReviews: 22.6 percent; Meta-analyses: 0.2 percent; Randomized controlled trials: 0.1 percentReviews22.6% (1,678)Meta-analyses0.2% (12)Randomized controlled trials0.1% (7)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 7,435 PubMed records
TypeRecordsShare
Reviews1,67822.6%
Meta-analyses120.2%
Randomized controlled trials70.1%

Method: PubMed query "Genomic Imprinting"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in genetics and genomics

Genetic findings vary widely in strength. A variant linked to a condition in one study may not replicate in other ancestries, and most common variants have small effects that are meaningful only in aggregate. Studies of rare, high-impact variants can support strong causal claims about a gene, while association studies describe statistical links that need functional and independent replication. Check the sample size, the ancestry of participants, whether results were replicated, and whether a laboratory or clinical outcome was actually measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
ZNF445 is a primary regulator of genomic imprinting
Takahashi N, Coluccio A, Thorball CW, Planet E, Shi H, Offner S, et al.
2019Research article
Design not recorded in structured metadata
170cc by
PMID 30602440 · DOI · PMC6317318
LncRNA Structural Characteristics in Epigenetic Regulation
Wang C, Wang L, Ding Y, Lu X, Zhang G, Yang J, et al.
2017Review article
Design not recorded in structured metadata
144cc by
PMID 29292750 · DOI · PMC5751261
Using long-read sequencing to detect imprinted DNA methylation
Gigante S, Gouil Q, Lucattini A, Keniry A, Beck T, Tinning M, et al.
2019Research article
Design not recorded in structured metadata
117cc by
PMID 30793194 · DOI · PMC6486641
mRNA 3' UTRs direct microRNA degradation to participate in imprinted gene networks and regulate growth
Lin DH, Elcavage LE, Khalizeva E, Bartel DP
2026Research article
Design not recorded in structured metadata
3cc by
PMID 41871909 · DOI · PMC13041716

ZNF445 is a primary regulator of genomic imprinting [1]

Research article Takahashi N, Coluccio A, Thorball CW, Planet E, Shi H, Offner S, et al. · · 2019 · cited 170 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Genomic imprinting is an epigenetic process regulated by germline-derived DNA methylation, causing parental origin-specific monoallelic gene expression.
Closing excerpt
In mice, ZFP445 and ZFP57 act together, maintaining all but one ICR in vivo, whereas earlier embryonic expression of ZNF445 and its intolerance to loss-of-function mutations indicate greater importance in the maintenance of human imprints.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (102 words)

Genomic imprinting is an epigenetic process regulated by germline-derived DNA methylation, causing parental origin-specific monoallelic gene expression. Zinc finger protein 57 (ZFP57) is critical for maintenance of this epigenetic memory during post-fertilization reprogramming, yet incomplete penetrance of ZFP57 mutations in humans and mice suggests additional effectors. We reveal that ZNF445/ZFP445, which we trace to the origins of imprinting, binds imprinting control regions (ICRs) in mice and humans. In mice, ZFP445 and ZFP57 act together, maintaining all but one ICR in vivo, whereas earlier embryonic expression of ZNF445 and its intolerance to loss-of-function mutations indicate greater importance in the maintenance of human imprints.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 30602440 · DOI · PMC6317318

LncRNA Structural Characteristics in Epigenetic Regulation [2]

Review article Wang C, Wang L, Ding Y, Lu X, Zhang G, Yang J, et al. · · 2017 · cited 144 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The rapid development of new generation sequencing technology has deepened the understanding of genomes and functional products.
Closing excerpt
This paper mainly discusses the correlation between the structure and function of lncRNAs with the recent progress in epigenetic regulation, which is important to the understanding of the mechanism of lncRNAs in physiological and pathological processes.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (122 words)

The rapid development of new generation sequencing technology has deepened the understanding of genomes and functional products. RNA-sequencing studies in mammals show that approximately 85% of the DNA sequences have RNA products, for which the length greater than 200 nucleotides (nt) is called long non-coding RNAs (lncRNA). LncRNAs now have been shown to play important epigenetic regulatory roles in key molecular processes, such as gene expression, genetic imprinting, histone modification, chromatin dynamics, and other activities by forming specific structures and interacting with all kinds of molecules. This paper mainly discusses the correlation between the structure and function of lncRNAs with the recent progress in epigenetic regulation, which is important to the understanding of the mechanism of lncRNAs in physiological and pathological processes.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 29292750 · DOI · PMC5751261

Using long-read sequencing to detect imprinted DNA methylation [3]

Research article Gigante S, Gouil Q, Lucattini A, Keniry A, Beck T, Tinning M, et al. · · 2019 · cited 117 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Systematic variation in the methylation of cytosines at CpG sites plays a critical role in early development of humans and other mammals.
Closing excerpt
Our analysis successfully identifies known imprinting control regions (ICRs) as well as some novel differentially methylated regions which, due to their proximity to hitherto unknown monoallelically expressed genes, may represent new ICRs.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (179 words)

Systematic variation in the methylation of cytosines at CpG sites plays a critical role in early development of humans and other mammals. Of particular interest are regions of differential methylation between parental alleles, as these often dictate monoallelic gene expression, resulting in parent of origin specific control of the embryonic transcriptome and subsequent development, in a phenomenon known as genomic imprinting. Using long-read nanopore sequencing we show that, with an average genomic coverage of ∼10, it is possible to determine both the level of methylation of CpG sites and the haplotype from which each read arises. The long-read property is exploited to characterize, using novel methods, both methylation and haplotype for reads that have reduced basecalling precision compared to Sanger sequencing. We validate the analysis both through comparison of nanopore-derived methylation patterns with those from Reduced Representation Bisulfite Sequencing data and through comparison with previously reported data. Our analysis successfully identifies known imprinting control regions (ICRs) as well as some novel differentially methylated regions which, due to their proximity to hitherto unknown monoallelically expressed genes, may represent new ICRs.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 30793194 · DOI · PMC6486641

mRNA 3' UTRs direct microRNA degradation to participate in imprinted gene networks and regulate growth [4]

Research article Lin DH, Elcavage LE, Khalizeva E, Bartel DP · · 2026 · cited 3 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
MicroRNAs direct downregulation of target mRNAs.
Closing excerpt
Thus, 3' UTRs can participate in parental conflict not only by regulating protein production but also by engaging TDMD to access an additional layer of regulation within a network of imprinted and biallelic genes.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (201 words)

MicroRNAs direct downregulation of target mRNAs. Sometimes, however, this regulatory paradigm inverts, and a target RNA triggers degradation of a microRNA. This target-directed microRNA degradation (TDMD) requires ZSWIM8. Zswim8 -/- mice exhibit reduced growth and perinatal lethality, accompanied by stabilization of >40 microRNAs. Nonetheless, studies of TDMD function in mammals have been limited because only two TDMD-triggering RNAs have been identified in mice. Here, we computationally identify and validate five new TDMD-triggering sites in mouse models. One site in Atp6v1g1 and two sites in Lpar4 direct degradation of miR-335-3p, showing that in mammals, two sites in the same transcript and multiple sites in different transcripts can collaborate to destabilize a microRNA. Moreover, sites in Plagl1 and Lrrc58 direct degradation of miR-322 and miR-503, respectively. Mice lacking the Plagl1 and Lrrc58 sites were smaller, demonstrating that target-directed degradation of miR-322 and miR-503 promotes growth. Both miR-335-3p and Plagl1 are maternally imprinted, implying their participation in parental conflict, but their corresponding triggers or target microRNA partners are not imprinted. Thus, 3' UTRs can participate in parental conflict not only by regulating protein production but also by engaging TDMD to access an additional layer of regulation within a network of imprinted and biallelic genes.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41871909 · DOI · PMC13041716

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Genomic imprinting in mammals [5]
    Barlow DP, Bartolomei MS · Cold Spring Harb Perspect Biol · 2014 · cited 548 times (Europe PMC)
  • Research article Genomic Imprinting and Physiological Processes in Mammals [6]
    Tucci V, Isles AR, Kelsey G, Ferguson-Smith AC, Erice Imprinting Group · Cell · 2019 · cited 443 times (Europe PMC)
  • Research article Mammalian genomic imprinting [7]
    Bartolomei MS, Ferguson-Smith AC · Cold Spring Harb Perspect Biol · 2011 · cited 401 times (Europe PMC)
  • Research article Genomic imprinting disorders: lessons on how genome, epigenome and environment interact [8]
    Monk D, Mackay DJG, Eggermann T, Maher ER, Riccio A · Nat Rev Genet · 2019 · cited 315 times (Europe PMC)
  • Research article Mechanisms regulating imprinted genes in clusters [9]
    Edwards CA, Ferguson-Smith AC · Curr Opin Cell Biol · 2007 · cited 309 times (Europe PMC)
  • Research article The long and the short of noncoding RNAs [10]
    Brosnan CA, Voinnet O · Curr Opin Cell Biol · 2009 · cited 276 times (Europe PMC)

References

  1. Takahashi N, Coluccio A, Thorball CW, Planet E, Shi H, Offner S, et al.. ZNF445 is a primary regulator of genomic imprinting. . 2019. PMID 30602440 · DOI · PMC6317318
  2. Wang C, Wang L, Ding Y, Lu X, Zhang G, Yang J, et al.. LncRNA Structural Characteristics in Epigenetic Regulation. . 2017. PMID 29292750 · DOI · PMC5751261
  3. Gigante S, Gouil Q, Lucattini A, Keniry A, Beck T, Tinning M, et al.. Using long-read sequencing to detect imprinted DNA methylation. . 2019. PMID 30793194 · DOI · PMC6486641
  4. Lin DH, Elcavage LE, Khalizeva E, Bartel DP. mRNA 3' UTRs direct microRNA degradation to participate in imprinted gene networks and regulate growth. . 2026. PMID 41871909 · DOI · PMC13041716
  5. Barlow DP, Bartolomei MS. Genomic imprinting in mammals. Cold Spring Harb Perspect Biol. 2014. PMID 24492710 · DOI · PMC3941233
  6. Tucci V, Isles AR, Kelsey G, Ferguson-Smith AC, Erice Imprinting Group. Genomic Imprinting and Physiological Processes in Mammals. Cell. 2019. PMID 30794780 · DOI
  7. Bartolomei MS, Ferguson-Smith AC. Mammalian genomic imprinting. Cold Spring Harb Perspect Biol. 2011. PMID 21576252 · DOI · PMC3119911
  8. Monk D, Mackay DJG, Eggermann T, Maher ER, Riccio A. Genomic imprinting disorders: lessons on how genome, epigenome and environment interact. Nat Rev Genet. 2019. PMID 30647469 · DOI
  9. Edwards CA, Ferguson-Smith AC. Mechanisms regulating imprinted genes in clusters. Curr Opin Cell Biol. 2007. PMID 17467259 · DOI
  10. Brosnan CA, Voinnet O. The long and the short of noncoding RNAs. Curr Opin Cell Biol. 2009. PMID 19447594 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • RNA InterferenceGenetics and Genomics
  • CRISPR-Cas SystemsGenetics and Genomics
  • X Chromosome InactivationGenetics and Genomics
  • DNA AdductsGenetics and Genomics
  • Genetic BackgroundGenetics and Genomics
  • Gene RearrangementGenetics and Genomics

All 95 articles in Genetics and Genomics →

At a glance

7,435
PubMed records on this heading
12%
published since 2020
1,678
review articles
7
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • RNA InterferenceGenetics and Genomics
  • CRISPR-Cas SystemsGenetics and Genomics
  • X Chromosome InactivationGenetics and Genomics
  • DNA AdductsGenetics and Genomics
  • Genetic BackgroundGenetics and Genomics

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support